Ethyl 3-hydroxy-8,9-dihydro-5H-pyridazino[3,4-d]azepine-7(6H)-carboxylate, 95.0%, 250mg

Methyl 1H-pyrazole-4-carboxylate hydrochloride, 95.0%, 100g

(S)-4-((tert-Butoxycarbonyl)amino)-5-methoxy-5-oxopentanoic acid, 95.0%, 100g

2-Amino-N-cyclopropylbenzamide, 95.0%, 500mg

2-(2,4-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

1-Methyl-4-nitro-1H-pyrazole, 98.0%, 1g

METHYL 4-METHYLPYRIDIN-3-YLCARBAMATE, 97.0%, 5g

Bromoéthane, min 99,5%, pour synthèse, 250 ml, conditionnement verre

3-(4-Chlorobutyl)-1H-indole-5-carbonitrile, 95.0%, 5g

tert-Butyl (3-hydroxy-4-methylphenyl)carbamate, 97.0%, 250mg

5-Methyl-3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazole, 5g

(2-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid, 95.0%, 10g

2-(3-((4-Bromo-2-chlorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g